医学
观察研究
冲程(发动机)
血压
随机对照试验
急性中风
缺血
并发症
内科学
缺血性中风
心脏病学
脑缺血
阶段(地层学)
重症监护医学
组织纤溶酶原激活剂
工程类
生物
机械工程
古生物学
作者
Georgios Tsivgoulis,George Ntaios
出处
期刊:Neurology
[Ovid Technologies (Wolters Kluwer)]
日期:2012-10-11
卷期号:79 (20): 2014-2015
被引量:13
标识
DOI:10.1212/wnl.0b013e3182749f7e
摘要
Poststroke hypertension is a common complication of acute cerebral ischemia (ACI) occurring in up to 80% of acute ischemic stroke (AIS) patients.(1) Despite its high prevalence, the optimal management of arterial hypertension during the acute stroke stage has not been established and remains an issue of long-lasting debate and little consensus.(1) Notably, the findings of numerous observational studies that have evaluated the association of acute blood pressure (BP) values with early stroke outcomes are contradictory and the available but underpowered randomized controlled trials (RCTs) have yielded inconsistent results.(2,3).
科研通智能强力驱动
Strongly Powered by AbleSci AI